Opus Medical Therapies

About:

Opus Medical Therapies is developing transcatheter mitral and tricuspid valve replacement products.

Website: http://www.opus-medical.com

Description:

Opus Medical Therapies is developing transcatheter mitral and tricuspid valve replacement products for patients undergoing mitral and tricuspid valve disease. It is focused on addressing the challenging mitral regurgitation market.

Total Funding Amount:

$4.75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Atlanta, Georgia, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)opus-medical.com

Founders:

Ed L. Chang, Jaime Sarabia, Vivek Rajagopal, Yen Liao

Number of Employees:

1-10

Last Funding Date:

2020-09-04

IPO Status:

Private

Industries: